COMP <GO>
ALHC vs ABBV // GROSS PROFIT MARGIN
Alignment Healthcare Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: ALHC 2
— ABBV 9
■ METRIC PARITY
LAST: $8.06 (-1.47%) • MKT CAP: $1.67B
gross-margins
—
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
gross-margins
70.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALHC VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALHC | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 70.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 29.00% | -15.10 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.8x | 33.3x | +4.50 | ABBV | /valuation <GO> |
| Free Cash Flow Yield | 6.77% | 3.47% | +3.30 | ALHC | /fcf-yield <GO> |
| Operating Margin | 0.40% | 24.60% | -24.20 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 6.90% | -6.90 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 46.10% | 8.60% | +37.50 | ALHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.00 | 5.33 | -1.33 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.6 | 65.1 | -33.47 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.67B | $513.86B | -$512.19B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALHC REV | ABBV REV | ALHC GROSS % | ABBV GROSS % | ALHC FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.95B | $61.16B | — | 70.2% | $113.1M | $17.82B |
| FY 2024 | $2.70B | $56.33B | — | 70.0% | -$6.6M | $17.83B |
| FY 2023 | $1.80B | $54.32B | — | — | -$59.2M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALHC // BETA —
ABBV // BETA 1.15